Taken together, our studies suggested that PRKD3 regulated phosphorylation of ERK1, not ERK2, and then ERK1 stabilized c‐MYC by phosphorylation, leading to promote the proliferation of the breast cancer cells. This evidence concerns the gene MAPK1 and breast carcinoma.